-
□
Central access
-
□
Baseline laboratory investigations: ionized calcium, phosphate, alkaline phosphatase (ALP), parathyroid hormone (PTH), pyridoxal-5-phosphate (PLP), liver function, & renal function (blood); calcium & creatinine (urine)
-
□
Skeletal survey (if not already done)
-
□
Baseline renal ultrasound
-
□
Baseline eye exam
-
□
Hearing screen
-
□
Education of the primary care team (including bedside nursing and allied health professionals) about the disease and the treatment, including potential complications and outcomes
-
□
Consultation with relevant medical subspecialties (e.g., Medical Genetics, Endocrinology, Respirology, Neurology, Orthopaedics)
Daily*:
-
□
Assessment of respiratory support needs (if applicable)
-
□
Assessment of sedation and analgesia requirements (if applicable)
-
□
Bedside nurse subjective impression of response to handling
Twice weekly*: Weekly*:
-
□
Head circumference and length
-
□
Nutritional review
-
□
Laboratory investigations: calcium & creatinine (urine)
-
□
Scheduled family meeting
-
□
Team meeting to review treatment course, evidence of response/non-response, and drug dosing
Every two weeks*: Monthly*:
-
□
Eye exam for increased intracranial pressure and calcium deposition
-
□
Renal ultrasound for nephrocalcinosis
-
□
Multidisciplinary meeting to review treatment course and evidence of response/non-response
-
□
Unified recommendation regarding continuation of therapy
As needed:
-
□
STAT ionized calcium level, treatment with pyridoxine, and standard-of-care investigations and treatment, for seizures
-
□
Standard-of-care investigations and treatment, including consideration of gastrostomy tube, for feeding difficulties
-
□
Craniofacial CT scan (low dose - bone only), for craniosynostosis and related complications
-
□
Consultation with hospital bioethicist
*And as needed |